Navigation Links
Creating an 'electronic nose' to sniff out tuberculosis from a patient's breath
Date:11/7/2011

A new hand-held device called the Electronic Nose, which has the potential to diagnose tuberculosis (TB) in symptomatic patients, was awarded a $950,000 grant from Grand Challenges Canada and the Bill & Melinda Gates Foundation today to support further development and testing of this ground-breaking technology.

The funding will help determine whether the Electronic Nose is able to detect TB immediately and non-invasively from the patient's breath, in order to replace time-consuming testing with sputum.

It is estimated that up to 400,000 lives a year can be saved in the developing world by early diagnosis, immediate treatment and reduced transmission of this killer disease.

TB has been all but eliminated in the developing world, but in poor countries it claims close to 1.7 million lives yearly and is second only to HIV/AIDs as the world's most deadly infectious disease.

"This important discovery is testimony to the power of innovation to save lives," said Dr. Peter Singer, CEO of Grand Challenges Canada. "Diagnosing TB and other pulmonary disease simply by testing a patient's breath is a bold idea with potentially big impact."

The development of the Electronic Nose is a collaboration between the International Centre for Genetic Engineering and Biotechnology in New Delhi, India, and Next Dimension Technologies in California. The New Delhi innovators are working with sensors developed in California to track biomarkers in the breath. Those biomarkers may hold promise to identify TB disease, leading to earlier diagnosis and improved patient treatment.

"We hope to take the concept of the Electronic Nose to the next level by developing and testing a prototype of the hand-held, battery-powered device," said Prof. Virander Chauhan and Dr. Ranjan Nanda, lead researchers. "Our goal is to make the Electronic Nose widely available in poor, remote areas where tuberculosis often breeds and spreads, devastating so
'/>"/>

Contact: Terry Collins
tc@tca.tc
416-538-8712
McLaughlin-Rotman Centre for Global Health
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Better beer: College team creating anticancer brew
2. Argonne scientists discover possible mechanism for creating handedness in biological molecules
3. Creating ideal neural cells for clinical use
4. Marine microbes creating green waves in industry
5. Marine microbes creating green waves in industry
6. Stimulus-funded university research addressing issues from climate change to cancer, creating jobs and training a new generation of scientists
7. Melting tundra creating vast river of waste into Arctic Ocean
8. Scientists are first to unlock the mystery of creating cultured pearls from the queen conch
9. Forest deal at Copenhagen must avoid creating carbon refugees
10. VAI researchers find long awaited key to creating drought resistant crops
11. Creating a dream breed
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Creating an 'electronic nose' to sniff out tuberculosis from a patient's breath
(Date:7/13/2015)... , Jul. 13, 2015 NXT-ID, Inc. ... a biometric authentication company focused on the growing ... filed provisional patent 62/188684 for BEHAVIORAL-DIRECTED ... another new convenient and secure method to make ... innovative payment methods, introduced with its groundbreaking voice-direct ...
(Date:7/8/2015)... 2015 Summary Pancreatic cancer is the ... fatal, with a mortality rate of 10.9 deaths per ... cancer patients has highlighted a significant need for new ... met by the current market. A highly active ... varying molecule types and mechanisms of action, which provides ...
(Date:7/7/2015)... VIEW, Calif. , July 7, 2015 /PRNewswire/ ... biometrics market, Frost & Sullivan recognizes Credence ID, ... Sullivan Entrepreneurial Company of the Year Award. ... suite to aid in its mission of offering ... under-recognized populations globally. As Credence ID was formed ...
Breaking Biology News(10 mins):NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5
... 2009 issue of the Journal of General Physiology ... University of British Columbia, Vancouver) and colleagues that explores ... using in vivo nonsense suppression technology. The study will ... According to Riccardo Olcese (UCLA) in a commentary accompanying ...
... DURHAM, N.H. Two University of New Hampshire ... (NSF) Faculty Early Career Development (CAREER) grants. Vaughn ... biomedical sciences received $1 million to better understand ... students in data collection. Christopher White of the ...
... Mountain goats are no exception to the general ... healthier offspring. But University of Alberta researcher David Coltman ... mountain goats think twice about their romantic partners. ... taking the eligible females for themselves. The larger males ...
Cached Biology News:2 UNH faculty receive $1.4M in CAREER grants from NSF 2
(Date:7/30/2015)... ... July 30, 2015 , ... Leading regenerative veterinary medicine company, ... canine osteoarthritis stem cell product, currently under development for FDA approval. The product ... marketed in the US by Aratana. This product, termed AT-016, is an allogeneic ...
(Date:7/30/2015)... 30, 2015 Ascendis Pharma A/S (Nasdaq: ... its innovative TransCon technology to address significant unmet ... a six-month Phase 2 study to evaluate the ... in 53 treatment-naïve, pre-pubertal children with growth hormone ... pleased with the top-line results from our Phase ...
(Date:7/30/2015)... ... July 30, 2015 , ... GEA's Pony™ NS2006L ... operation up to 1500 bar. The sanitary design gauge of the NS2006L is ... , The Pony™ NS2006L homogenizer is an ideal solution for the processing of ...
(Date:7/29/2015)... US-Australian drug discovery company, Novogen Limited (ASX: ... committed to progressing its ground-breaking technology platforms to Phase ... ensure the Company delivers the best value for shareholders. ... , said the Company currently had an extensive program ... programs and academic partnerships and initiatives, and he was ...
Breaking Biology Technology:VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7GEA Announces the Pony™ NS2006L… a Self-contained, High Pressure Lab Homogenizer for Product Development Ensuring Maximum Efficiency and Safety 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10
... Reagents to ... Advance Cancer Research, NEWARK, ... ) -- a leader in providing advanced antibody,products and services ... by Science Applications International Corporation - Frederick,(SAIC-F), to develop monoclonal ...
... 7 at 1:45 PM, DALLAS, April 3, 2008 ... digital health research at ATA 2008 at the,Washington State ... Harry will highlight findings from Private Insurance and ... insurance industry featuring,interviews with twenty senior executives from the ...
... Ratcliff, the,award-winning architecture, planning and interiors firm, master ... tower,accompanied by a 767-stall parking garage and 20,000-square-foot ... Walnut Creek Campus. The Thomas J.,and Muriel T. ... will add,230 private and six semi-private rooms, increasing ...
Cached Biology Technology:Strategic Diagnostics Inc. Selected as Key Supplier to SAIC-F and the National Cancer Institute for the Development of a Comprehensive Portfolio of Antibodies for Use in Cancer Research 2Strategic Diagnostics Inc. Selected as Key Supplier to SAIC-F and the National Cancer Institute for the Development of a Comprehensive Portfolio of Antibodies for Use in Cancer Research 3Parks Associates' Digital Health Analyst to Present Latest Research and Forecasts at ATA Show 2Ratcliff Designs Hospital of the Future for John Muir Medical Center - Walnut Creek Campus 2Ratcliff Designs Hospital of the Future for John Muir Medical Center - Walnut Creek Campus 3
Standard 2" or 3" Plastic can be ordered with 81 or 100 cell dividers. Mini 2" Plastics Boxes come standard with 25 cell dividers. Plastic boxes can also be ordered with corresponding freezer racks...
Ultra Pure Grade. Used in conjunction with IPTG to identify bacterial colonies that contain recombinant plasmids by blue/white selection. X-Gal forms an intense blue precipitate in the presence of be...
Request Info...
4-Hydroxy-3-nitrophenylacetyl hapten is conjugated to KLH (Keyhole Limpet Hemocyanin) lysine through amide bonds....
Biology Products: